Cargando…
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer
PURPOSE: Vincristine (VCR) is a chemotherapeutic agent used in the treatment of pediatric oncology patients, but its main toxicity is VCR‐induced peripheral neuropathy (VIPN). However, whether VIPN has an effect on health‐related quality of life (HR‐QoL) in children during treatment is unknown. Ther...
Autores principales: | van de Velde, Mirjam E., van den Berg, Marleen. H., Kaspers, Gertjan J. L., Abbink, Floor C. H., Twisk, Jos W. R., van der Sluis, Inge M., van den Bos, Cor, van den Heuvel‐Eibrink, Marry M., Segers, Heidi, Chantrain, Christophe, van der Werff Ten Bosch, Jutte, Willems, Leen, van Litsenburg, Raphaële R. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607258/ https://www.ncbi.nlm.nih.gov/pubmed/34725942 http://dx.doi.org/10.1002/cam4.4289 |
Ejemplares similares
-
Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial)
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020) -
Randomized controlled trial on the effect of 1‐hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)
por: Uittenboogaard, Aniek, et al.
Publicado: (2023) -
Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745
por: van de Velde, Mirjam Esther, et al.
Publicado: (2023) -
Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam E., et al.
Publicado: (2022) -
Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020)